Tag: SynchroMed II

First patient enrolled in Embrace targeted drug delivery clinical study

The first patient has been enrolled in the Embrace TDD (targeted drug delivery) clinical study that will evaluate the use of the SynchroMed II...
Medtronic logo

Medtronic launches the Control Workflow to help eliminate oral opioids and...

Medtronic has announced the US launch of the Control Workflow, an evidence-based approach for use with the SynchroMed II intrathecal drug delivery system ("Medtronic...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

FDA approves new clinician programmer for SynchroMed II intrathecal drug delivery...

The US Food and Drug Administration (FDA) has approved a new clinician programmer for use with the SynchroMed II Intrathecal Drug Delivery system (Medtronic),...